Literature DB >> 22795418

Acute kidney injury risk in patients with ST-segment elevation myocardial infarction at presentation to the ED.

Rafaela Elizabeth Bayas Queiroz1, Leilane Siqueira Nobre de Oliveira, Cláudio Alves de Albuquerque, Caroline de Alencar Santana, Patrícia Maia Brasil, Luzia Layla Rodrigues Carneiro, Alexandre Braga Libório.   

Abstract

INTRODUCTION: Acute kidney injury (AKI) is common in acute myocardial infarction (AMI) patients and has serious prognostic implications. The early identification of patients at risk of developing AKI at the emergency department (ED) can reduce its incidence.
METHODS: Patients with ST-segment elevation myocardial infarction (STEMI) at the ED were included. Associated factors playing a role at ED presentation and during hospitalization were collected, and independent risk factors of developing AKI were assessed.
RESULTS: Mean age among patients (n = 406, 69.7% male) was 62.5 ± 12.5 years. At ED admission, the mean glomerular filtration rate (GFR) was 70.5 ± 28.1 mL/min per 1.73 m(2), and 140 (34.5%) patients had a GFR <60 mL/min per 1.73 m(2). Eighty-three patients (20.4%) developed AKI: 47 (11.6%) with stage 1, 26 (6.4%) with stage 2 and 10 (2.5%) with stage 3. Mortality was 11.8% and was higher in patients with AKI (34.9% vs 5.9%, P < .0001). Univariate analysis disclosed age, reduced GFR at presentation, severe Killip class, heart rate and longer door-to-needle time as risk factors to develop AKI. Moreover, these patients received less β-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker in the ED. Multivariate analysis revealed that age, Killip class, heart rate, door-to-needle time, and β-blocker non-use were independent factors associated with AKI. These factors provided the ED physician with good accuracy in identifying patients at high risk of developing AKI.
CONCLUSION: Factors associated with AKI in STEMI patients allowed physicians to identify patients at high risk in the ED. Moreover, reduced door-to-needle time and β-blocker use were associated with renal protection in AMI patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795418     DOI: 10.1016/j.ajem.2012.04.011

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  12 in total

1.  The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke.

Authors:  Michael Robert Marchick; Brandon Russell Allen; Emily Cassin Weeks; Jonathan Jacob Shuster; Marie-Carmelle Elie
Journal:  Intern Emerg Med       Date:  2016-02-24       Impact factor: 3.397

2.  Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention.

Authors:  Gilad Margolis; Amir Gal-Oz; Sevan Letourneau-Shesaf; Shafik Khoury; Gad Keren; Yacov Shacham
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

3.  Clinical prediction scores for type 1 cardiorenal syndrome derived and validated in chinese cohorts.

Authors:  Hong Cheng; Yi-Pu Chen
Journal:  Cardiorenal Med       Date:  2014-12-13       Impact factor: 2.041

4.  Development of a novel score to predict the risk of acute kidney injury in patient with acute myocardial infarction.

Authors:  Khalid Abusaada; Cai Yuan; Rafay Sabzwari; Khurram Butt; Aadil Maqsood
Journal:  J Nephrol       Date:  2016-06-14       Impact factor: 3.902

5.  Early β-blockers administration might be associated with a reduced risk of contrast-induced acute kidney injury in patients with acute myocardial infarction.

Authors:  Jin Liu; Guoli Sun; Yibo He; Feier Song; Shiqun Chen; Zhaodong Guo; Bowen Liu; Li Lei; Lihao He; Jiyan Chen; Ning Tan; Yong Liu
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 6.  The Influence of Acute Kidney Injury on Acute Cardiovascular Disease.

Authors:  Hsing-Shan Tsai; Yung-Chang Chen; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

7.  Contrast induced acute kidney injury and the role of beta-blockers in its prevention.

Authors:  Umberto Barbero; Mario Iannaccone; Michele De Benedictis; Baldassarre Doronzo
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

8.  Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Marco Moltrasio; Mara Rubino; Gabriele Crimi; Stefano Buratti; Marco Grazi; Valentina Milazzo; Alberto Somaschini; Rita Camporotondo; Stefano Cornara; Monica De Metrio; Alice Bonomi; Fabrizio Veglia; Gaetano M De Ferrari; Antonio L Bartorelli
Journal:  J Am Heart Assoc       Date:  2016-07-06       Impact factor: 5.501

9.  Derivation and validation of a prediction score for acute kidney injury secondary to acute myocardial infarction in Chinese patients.

Authors:  Feng-Bo Xu; Hong Cheng; Tong Yue; Nan Ye; He-Jia Zhang; Yi-Pu Chen
Journal:  BMC Nephrol       Date:  2019-05-30       Impact factor: 2.388

10.  Combination of Amino-Terminal Pro- BNP , Estimated GFR , and High-Sensitivity CRP for Predicting Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients.

Authors:  De-Qiang Zhang; Hong-Wei Li; Hai-Ping Chen; Qing Ma; Hui Chen; Yun-Li Xing; Xue-Qiao Zhao
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.